Major Pharma News Highlights, October to December 2017

Torrent Pharma to buy Unichem’s India business: Torrent Pharmaceuticals  has entered into a agreement with Unichem to buy its business in India, Nepal for Rs3,600 crore. Ajanta Pharma retains the tag of fastest wealth creator for the third time in a row: TCS biggest wealth creator in 2012-17, Ajanta Pharma the fastestweath creator in 2017. Asian Read more about Major Pharma News Highlights, October to December 2017[…]

Pharma News, August And September 2017, Highlights Pill

Govt proposal to scrap loan licensing in draft pharma policy faces flak: The draft pharma policy’s plan to do away with loan licensing would lead to revenue loss for SMEs, disrupt the supply chain and make installed capacities redundant, says industry. IDMA said that more than 40% of drug production is generated through loan licensing. The Read more about Pharma News, August And September 2017, Highlights Pill[…]

July 2017. Major Pharma News Highlights Pill

Sun Pharma has appointed Samsung BioLogics to manufacture Tildrakizumab, an investigational IL-23p19 inhibitor being evaluated for the treatment of moderate to severe plaque psoriasis. The Centre has stalled a $1.3-billion bid by Shanghai Fosun Pharmaceutical Group (SFP) to acquire an 86% stake+ in Hyderabad-based Gland Pharma, citing “genuine concerns” over proprietary technology developed by the Read more about July 2017. Major Pharma News Highlights Pill[…]

June 2017. Pharma News Highlights Pill

Elder Pharmaceuticals has filed for insolvency, in an attempt to restructure its debt. It had an unpaid debt of around Rs 1,000 crore as on end of June 2014. Trading of its shares has been suspended on the bourses. Bengal Chemicals & Pharmaceuticals (BCPL), India’s oldest pharma company of 125 years has just turned profitable after 64 Read more about June 2017. Pharma News Highlights Pill[…]

Pharma News, May 2017 Major Highlights Pill

Cadila Healthcare Ltd has become India’s second-most valuable pharmaceutical company in terms of market capitalisation, ahead of drug makers such as Lupin Ltd, Dr Reddy’s Laboratories Ltd and Cipla Ltd that have higher revenues. Now it ranks at the 47th position in overall market cap among all industries ranking on the BSE. Sun Pharmaceuticals Industries Ltd Read more about Pharma News, May 2017 Major Highlights Pill[…]

NIPER Mohali Second Rank in Pharmacy Category, Vows to reach Top

NIPER mohali participated first time in a survey conducted by National Institutional Ranking Framework (NIRF), Ministry of Human Resource Development, Government of India for National Ranking of the Institutes / Universities. It has adjudged, National Institute of Pharmaceutical Education and Research (NIPER), S.A.S. Nagar (Mohali) Second in the country in Pharmacy category. As per data Read more about NIPER Mohali Second Rank in Pharmacy Category, Vows to reach Top[…]

About iPHEX, International Exhibition For Pharma and Healthcare

iPHEX IS An exhibition that brings together the drugs, pharmaceutical and healthcare industry – all under one roof 5th Edition Of this mega pharma show was held during 27-29th April, 2017 at Hitex Exhibition Center, Hyderabad. 580 overseas buyers from about 110 countries participated in the iPEX 2017 exhibition. 275 exhibitors participated. iPHEX showcased Indian Read more about About iPHEX, International Exhibition For Pharma and Healthcare[…]

Pharma News, April 2017 Highlights Pill

USFDA issues Warning Letter To Divis Labs For Vishakhapatnam Unit Sun Pharma Indirect Arm To Acquire Thallion Pharmaceuticals Drug firm Cipla’s subsidiary in South Africa has completed the acquisition of Anmarate (Pty) Ltd, South Africa, a deal estimated at around ZAR 26 million. India’s antitrust regulator has ordered a probe into Swiss drugmaker Roche for allegedly Read more about Pharma News, April 2017 Highlights Pill[…]

Pharma News, March 2017 Highlights Pill

NPPA has alleged that the listed 634 drugs are being sold at prices higher than their ceiling price fixed by the Drug Price Control Order (DPCO). The list includes Pharma giants, Sun Pharmaceuticals, Lupin Pharma, Cipla, Cadila Healthcare and many more. According to rating agency ICRA domestic pharmaceutical industry is likely to register moderate growth largely owing to increased Read more about Pharma News, March 2017 Highlights Pill[…]

Pharma News, February 2017 Highlights Pill

Delhi High Court gives Biocon, Mylan green light to market blockbuster biosimilar for three cancers drugs Government is set to impose a ceiling of Rs 1,000 on the gift to doctors: In a move to curb the unethical practice of pharma companies seeking to influence doctors and chemists through expensive “gifts”, the government is set to impose Read more about Pharma News, February 2017 Highlights Pill[…]

Pharma News, January 2017 Highlights Pill

PHARMA In Budget 2017: The move to eradicate certain Non Communicable Diseases, the proposal to set up two new AIIMS, additional post-graduate medical seats, proposed amendments in the Drugs and Cosmetics Rules and new rules for medical devices are welcome. Shares of pharmaceutical companies slipped on 1 Febraury after the Union Finance Minister Arun Jaitley proposed Read more about Pharma News, January 2017 Highlights Pill[…]

Skip to toolbar